文献速递消化内镜消化道肿瘤与早癌

隧道内镜黏膜下剥离术治疗食管鳞癌的临床获益:多中心随机对照试验

Clinical benefit of tunnel endoscopic submucosal dissection for esophageal squamous cancer: a multicenter, randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2022-04-22

在中国5家医院开展的前瞻性多中心随机对照试验,纳入160例食管鳞状上皮肿瘤患者,随机分为传统ESD组与隧道ESD组,最终152例纳入分析。主要终点手术时间两组中位数差异未达统计学显著(47.3分钟 vs 40.0分钟,P=.095),但病变周径≥1/2者隧道ESD中位手术时间较传统ESD缩短34.5%(29.5分钟,P<.001);隧道ESD组肌肉损伤更少(18.4% vs 38.2%,P=.007),术后1个月人工黏膜缺损完全愈合更常见(95.9% vs 84.7%,P=.026)。

要点

  • 隧道ESD较传统ESD缩短周径≥1/2食管病变的中位手术时间34.5%(29.5分钟)(P<.001)。
  • 隧道ESD组肌肉损伤发生率低于传统ESD组(18.4% vs 38.2%,P=.007)。
  • 术后1个月人工黏膜缺损完全愈合率隧道ESD组高于传统ESD组(95.9% vs 84.7%,P=.026)。

核心结论

  • 研究表明隧道ESD可缩短手术时间,尤其是对周径≥1/2的食管病变。
  • 隧道ESD安全性更好,表现为肌肉损伤更少、ESD所致人工黏膜缺损愈合改善。

研究设计与样本

  • 前瞻性多中心随机对照试验,在中国5家医院开展。
  • 纳入食管鳞状上皮肿瘤患者,随机分为传统ESD组或隧道ESD组,按肿瘤位置和周径范围(<1/2或≥1/2)分层随机化。
  • 2018年1月至7月共入组160例,最终152例纳入分析(传统ESD组76例,隧道ESD组76例)。
  • 主要终点为手术时间。

主要发现

  • 传统ESD组中位手术时间47.3分钟(四分位距31.7-81.3),隧道ESD组40.0分钟(四分位距30.0-60.0),P=.095。
  • 对周径≥1/2的病变,隧道ESD较传统ESD中位手术时间缩短34.5%(29.5分钟),P<.001。
  • 肌肉损伤隧道ESD组18.4% vs 传统ESD组38.2%,P=.007。
  • 术后1个月人工黏膜缺损完全愈合隧道ESD组95.9% vs 传统ESD组84.7%,P=.026。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is widely accepted as a primary treatment modality for dysplastic and early cancerous lesions of the GI tract. However, prolonged procedure time and life-threatening adverse events remain obstacles to the successful treatment of esophageal cancer. This study aimed to compare the efficacy and safety of tunnel ESD (T-ESD) with conventional ESD (C-ESD) for superficial esophageal squamous neoplasms. METHODS: A prospective, multicenter trial was conducted at 5 hospitals in China. Patients with esophageal squamous neoplasms were enrolled and randomly assigned to undergo C-ESD or T-ESD. Randomization was stratified by tumor location and circumference extent (<1/2 or ≥1/2). The primary endpoint was procedure time. RESULTS: Between January and July 2018, 160 patients were enrolled. One hundred fifty-two patients (76 in the C-ESD group and 76 in the T-ESD group) were included in the final analysis. The median procedure time was 47.3 minutes (interquartile range, 31.7-81.3) for C-ESD and 40.0 minutes (interquartile range, 30.0-60.0) for T-ESD (P = .095). However, T-ESD specifically reduced the median procedure time 34.5% (29.5 minutes) compared with C-ESD for lesions ≥1/2 circumference (P < .001). Among the multiple secondary outcomes, muscular injury was less frequent in the T-ESD group compared with the C-ESD group (18.4% vs 38.2%, P = .007), but complete healing of artificial mucosal defect in 1-month follow-up was more common in the T-ESD group than the C-ESD group (95.9% vs 84.7%, P =.026). CONCLUSIONS: Our study suggests that T-ESD results in shorter procedure time, specifically for lesions ≥1/2 circumference of the esophagus. In addition, T-ESD has a better safety profile indicated by less frequent muscular injury and improved healing of artificial mucosal defects caused by ESD procedures. (Clinical trial registration number: NCT03404921.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Fan X, Wu Q, Li R, et al. Clinical benefit of tunnel endoscopic submucosal dissection for esophageal squamous cancer: a multicenter, randomized controlled trial. Gastrointest Endosc. 2022. PMID: 35461890. doi:10.1016/j.gie.2022.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。